Sang Hoon Ahn
Overview
Explore the profile of Sang Hoon Ahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
560
Citations
10051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim D, Kim E, Lee J, Kim M, Kim B, Kim S, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002160
Background/objectives: Cytokine-induced killer (CIK) cell immunotherapy has shown promise in reducing recurrence and improving survival outcomes in hepatocellular carcinoma (HCC). We evaluated the efficacy and safety of CIK cell therapy...
2.
Rhee H, Kim M, Kim D, An C, Kang W, Han K, et al.
Gastroenterology
. 2025 Jan;
PMID: 39855314
Background & Aims: This study aimed to compare ultrasonography (US) and noncontrast magnetic resonance imaging (MRI) in the surveillance of hepatic malignancy. Methods: We conducted a randomized, nonblinded, single-center trial...
3.
Wu D, Kao J, Piratvisuth T, Wang X, Kennedy P, Otsuka M, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39838828
As new evidence emerges, treatment strategies toward the functional cure of chronic hepatitis B are evolving. In 2019, a panel of national hepatologists published a Consensus Statement on the functional...
4.
Lee H, Lee H, Kim E, Kim H, Kim H, Ahn S, et al.
Am J Gastroenterol
. 2025 Jan;
PMID: 39787330
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with incident cardiovascular disease (CVD). However, CVD risk could vary across and within individuals with MASLD. We investigated the cardiovascular implications...
5.
Shin G, Kim B, Bae S, Lee H, Ahn S
Clin Mol Hepatol
. 2024 Nov;
PMID: 39610193
No abstract available.
6.
Kim K, Yim S, Lee J, Joo D, Kim M, Park J, et al.
Aliment Pharmacol Ther
. 2024 Oct;
61(1):168-176.
PMID: 39392334
Background: Acute-on-chronic liver failure (ACLF) is a syndrome of patients with chronic liver disease presenting with multiple organ failures. Recently, Sundaram-ACLF-LT Mortality (SALT-M) score has been developed to predict 1-year...
7.
Shin G, Kim B, Bae S, Lee H, Ahn S
Clin Mol Hepatol
. 2024 Oct;
31(1):166-178.
PMID: 39363405
Background/aims: The World Health Organization (WHO) aims to eliminate hepatitis C virus (HCV) by 2030; therefore, widespread HCV screening is required. The WHO recommends HCV self-testing (HCVST) as a new...
8.
Kim K, Lee Y, Lee J, Kim M, Kim B, Kim S, et al.
J Gastroenterol Hepatol
. 2024 Sep;
39(12):2845-2852.
PMID: 39343427
Background And Aim: The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing worldwide, coinciding with aging population. However, limited studies have evaluated its incidence and progression to advanced...
9.
Han W, Han K, Hwang S, Ahn S, Kim M
JHEP Rep
. 2024 Sep;
6(10):101166.
PMID: 39314549
Background & Aims: We investigated the association of physical activity (PA) levels and changes with the risk of hepatocellular carcinoma (HCC) in patients with type 2 diabetes. Methods: Patients with...
10.
Lin H, Yip T, Lee H, Meng X, Lai J, Ahn S, et al.
J Hepatol
. 2024 Sep;
82(3):456-463.
PMID: 39307372
Background & Aims: Direct-acting antivirals (DAAs) have considerably improved chronic hepatitis C (HCV) treatment; however, follow-up after sustained virological response (SVR) typically neglects the risk of liver-related events (LREs). This...